Awarded contract

RMH - CAR-T Treatment

Details

Buyer: The Royal Marsden NHS Foundation Trusts
Value: GBP 380,000
Duration: 1 year
Topic: Pharmaceutical products
Published: 24 October 2025
Source: uk:find_a_tender

Tender description

CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Disciplinary Team (MDT). The product should meet strict NHS England standards for cryogenic storage and handling and RMH has such credentials. ## Contract award Title: RMH - CAR-T Treatment

Timeline

Completed: Award published24 October 2025
Current notice
Completed: Award date24 October 2025
Next: Contract expiry date31 October 2026in 2 months

About the buyer

The Royal Marsden NHS Foundation Trusts is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Commercial Director	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Procurement Manager	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Category Lead	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Senior Buyer	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Contracts Manager	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov